Tag: fighting-blood
-
AstraZeneca buys most of Acerta for $4 billion to add cancer drug
By Ben Hirschler LONDON (Reuters) – AstraZeneca said on Thursday it had agreed to buy 55 percent stake of privately held biotech firm Acerta Pharma for $4 billion to give it access to a new kind of drug for fighting blood cancers. AstraZeneca will pay $2.5 billion upfront, with a further $1.5 billion paid either…
-
High schools listening to scientists, letting teens sleep
SEATTLE (AP) — More school districts around the U.S. are heeding the advice of scientists who have long said that expecting teens to show up to class before 8 a.m. isn't good for their health or their report cards.
-
High schools listening to scientists, letting teens sleep
SEATTLE (AP) — More school districts around the U.S. are heeding the advice of scientists who have long said that expecting teens to show up to class before 8 a.m. isn't good for their health or their report cards.